A State Street Fund Excels in Rough Year for Healthcare Stocks
The healthcare sector has lagged the broader market, but this State Street fund outperformed its peers thanks to its market cap weighting.

Despite an early 2024 rally, healthcare shares continue to lag the broad market. Over the past 12 months, the S&P 500 Index climbed 22.1%; health stocks, a modest 13.5%. Enthusiasm about artificial intelligence (AI) stocks sapped investor attention from defensive sectors, including health.
Healthcare remains an attractive sector, although it doesn't move as one block. On the plus side, an ongoing post-COVID ramp-up in patients getting surgery and treatment is boosting health-facility stocks.
Weight-loss drugs and their potential to treat other ailments could lift earnings for key drug players for years. The sector even has an artificial intelligence angle, from accelerating drug research to precision medicine therapies. And though aging demographics is an old story, it remains a growth driver for the sector.

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Why we chose the Health Care Select Sector SPDR ETF
Last month in the Kiplinger ETF 20, our favorite cheap ETFs to buy, we replaced the Invesco S&P 500 Equal Weight Health Care ETF (RYH) with State Street Global Advisor's Health Care Select Sector SPDR Fund (XLV). Both funds hold the same 63 healthcare stocks, but the Invesco fund gives equal stakes to each firm and gained 5.9% over the past 12 months; the SPDR ETF weights each holding by market value and advanced 13.3%.
Size helped over the past year, and we think that trend will continue. Just 15 health stocks beat the S&P 500 over the past 12 months, and most rank among the largest by market cap. Sector heavyweight Eli Lilly (LLY) soared 78% over the past 12 months; biotech giants Regeneron Pharmaceuticals (REGN) and Amgen (AMGN) gained 45% and 46%, respectively.
By contrast, the rest of the sector was a drag. More than 20 stocks lost value over the past year, led by DexCom (DXCM), down 45%, which makes devices for people with diabetes.
Investors can expect the U.S. presidential election to inject some choppiness into health shares. Firms with strongholds in their businesses and heaps of cash on their balance sheets can best navigate that challenge, say BofA Securities analysts.
Note: This item first appeared in Kiplinger Personal Finance Magazine, a monthly, trustworthy source of advice and guidance. Subscribe to help you make more money and keep more of the money you make here.
Related content
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Nellie joined Kiplinger in August 2011 after a seven-year stint in Hong Kong. There, she worked for the Wall Street Journal Asia, where as lifestyle editor, she launched and edited Scene Asia, an online guide to food, wine, entertainment and the arts in Asia. Prior to that, she was an editor at Weekend Journal, the Friday lifestyle section of the Wall Street Journal Asia. Kiplinger isn't Nellie's first foray into personal finance: She has also worked at SmartMoney (rising from fact-checker to senior writer), and she was a senior editor at Money.
-
Expiring Business Tax Breaks And Trump's Tax Plan
The Tax Letter Four important business tax breaks are likely to be a part of President Trump's tax plan. We'll break them down for you.
By Joy Taylor Published
-
Stock Market Today: Trump's Tariff Reversal Can't Save Stocks
Panic selling sent the Nasdaq Composite into correction territory, while the Dow and S&P 500 suffered notable losses.
By Karee Venema Published
-
Stock Market Today: Trump's Tariff Reversal Can't Save Stocks
Panic selling sent the Nasdaq Composite into correction territory, while the Dow and S&P 500 suffered notable losses.
By Karee Venema Published
-
Six Steps to Simplify Your Estate for Your Heirs
A simplified estate strategy will expedite the settlement of your estate after you're gone, lower audit risk, reduce costs and cut your beneficiaries' stress.
By Howard Sharfman Published
-
Three Actions to Protect Wealth Transfer Amid Tax Uncertainty
How should families plan to pass on their wealth amid ongoing uncertainty over estate taxes? Even if TCJA provisions are extended, they might still be temporary.
By Brett W. Berg Published
-
Business Owners: How to Calculate Your Wealth Gap in Five Minutes
How much would you need from the sale of your business to retire without sacrificing your lifestyle? This simple calculation will give you an idea.
By Evan T. Beach, CFP®, AWMA® Published
-
Stock Market Today: Dow Adds 485 Points After Trump's Tariff Delay
The White House said it will postpone tariffs on automotive imports from Canada and Mexico for one month.
By Karee Venema Published
-
10 Ways to Refine Your Financial Plan for a More Secure Future
Significant benefits throughout the rest of the year can be had if you take some time now to revisit your financial plan and adjust accordingly.
By Jennifer T. Stephenson, CPA Published
-
The Most Important Number for a Business Owner Considering a Sale
Company owners hoping to sell and stop working won't know whether an offer on their business is good enough unless they know their 'wealth gap.'Evan
By Evan T. Beach, CFP®, AWMA® Published
-
Stock Market Today: Dow Drops 670 Points on Trade War Effect
A prodigious rally by the battered leader of the AI revolution typified an increasingly volatile picture for investors, traders and speculators.
By David Dittman Published